Scientists find promising pancreatic cancer leads
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Promising preliminary Phase 2b (ASCEND) pancreatic cancer data (Cohort A) reported with Cohort B data anticipated in the coming monthsEnrollment ...
Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
Top-line Phase 2/3 data readout for COMPANION-002, evaluating tovecimig (CTX-009 - a DLL4 x VEGF-A bispecific antibody) in patients with biliary ...
Yahoo Finance4 天
Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
BOSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics ...